Table 1

Baseline demographic, clinical, procedural and timing factors

VariableNo. of patientsCall-to-balloon time (mean min)No. of deaths at 30 days (%)
All patients16 907121.4898 (5.3)
Age group, years
 <554614 (27.3%)117.8103 (2.2)
 55–≤602159 (12.8%)117.572 (3.3)
 60–≤652353 (13.9%)118.692 (3.9)
 65–≤702104 (12.4%)120.096 (4.6)
 70–≤751889 (11.2%)124.4106 (5.6)
 75–≤801663 (9.8%)127.5129 (7.8)
 80–≤851216 (7.2%)130.2132 (10.9)
 >85906 (5.4%)130.7167 (18.4)
Gender
 Male12 509 (74.1%)119.6583 (4.7)
 Female4379 (25.9%)126.7314 (7.2)
Diabetes
 No14 245 (86.8%)120.3652 (4.6)
 Yes2166 (13.2%)127.4179 (8.3)
Hypertension
 No9630 (59.4%)119.5416 (4.3)
 Yes6581 (40.6%)123.2399 (6.1)
Hypercholesterolaemia
 No9868 (60.9%)120.8495 (5.0)
 Yes6343 (39.1%)121.3320 (5.0)
Smoking status
 Never5162 (33.7%)122.2281 (5.4)
 Ex3887 (25.4%)122.1195 (5.0)
 Current6278 (41.0%)117.8194 (3.1)
Peripheral vascular disease
 No15 681 (96.7%)120.7733 (4.7)
 Yes530 (3.3%)128.682 (15.5)
Cerebrovascular accident
 No15 577 (96.1%)120.6740 (4.8)
 Yes634 (3.9%)130.375 (11.8)
Renal disease
 No15 235 (98.7%)120.9708 (4.6)
 Yes205 (1.3%)132.944 (21.5)
Previous myocardial infarction
 No13 904 (88.1%)120.2669 (4.8)
 Yes1876 (11.9%)125.6144 (7.7)
Previous CABG
 No16 174 (97.9%)121.0839 (5.2)
 Yes342 (2.1%)134.724 (7.0)
Previous PCI
 No15 250 (92.0%)121.1783 (5.1)
 Yes1323 (8.0%)121.672 (5.4)
Cardiogenic shock pre-PCI
 No15 750 (93.4%)120.5502 (3.2)
 Yes1109 (6.6%)134.8392 (35.3)
Ventilated pre-PCI
 No14 354 (96.4%)119.2595 (4.1)
 Yes541 (3.6%)156.4227 (42.0)
Q wave on ECG
 No11 774 (81.8%)118.6534 (4.5)
 Yes2615 (18.2%)129.0241 (9.2)
TIMI flow pre-PCI
 TIMI 010 403 (73.7%)119.0608 (5.8)
 TIMI 1977 (6.9%)121.249 (5.0)
 TIMI 21280 (9.1%)124.658 (4.5)
 TIMI 31447 (10.3%)129.752 (3.6)
TIMI flow post-PCI
 TIMI 0842 (5.8%)120.7109 (12.9)
 TIMI 1185 (1.3%)130.540 (21.6)
 TIMI 2692 (4.7%)127.687 (12.6)
 TIMI 312 850 (88.2%)120.8552 (4.3)
Multi-vessel disease (>75% stenosis)
 1 vessel11 109 (70.5%)119.3410 (3.7)
 ≥2 vessels4655 (29.5%)124.2433 (9.3)
No. of vessels attempted
 Single15 278 (90.9%)120.8684 (4.5)
 Multi1535 (9.1%)126.6206 (13.4)
Arterial access
 Radial9065 (54.4%)119.5282 (3.1)
 Femoral7173 (43.1%)123.7554 (7.7)
 Joint/other416 (2.5%)127.947 (11.3)
Call time
 Weekday12 167 (72.0%)119.2670 (5.5)
 Weekend4740 (28.0%)127.1228 (4.8)
Call time (hours)
 08:00–18:009753 (57.7%)118.2529 (5.4)
 18:00–00:003213 (19.0%)124.5168 (5.2)
 00:00–08:003941 (23.3%)126.8201 (5.1)
Out of hours
 No7062 (41.8%)114.8389 (5.5)
 Yes9845 (58.2%)126.1509 (5.2)
Admission route
 Direct12 932 (77.2%)112.4655 (5.1)
 Transfer3102 (18.5%)162.8178 (5.7)
 Non-PPCI IP372 (2.2%)123.127 (7.3)
 PPCI IP355 (2.1%)88.330 (8.5)
Centre volume
 <1001237 (7.3%)108.192 (7.4)
 100–1991204 (7.1%)117.775 (6.2)
 ≥20014 466 (85.6%)122.9731 (5.1)
Symptom to call (min)
 ≤102321 (14.2%)121.4207 (8.9)
 >10–303206 (19.7%)118.7143 (4.5)
 >30–602939 (18.0%)118.8131 (4.5)
 >60–1202821 (17.3%)118.0113 (4.0)
 120–1801422 (8.7%)119.868 (4.8)
 >180–3601727 (10.6%)123.781 (4.7)
 >3601848 (11.3%)126.9108 (5.8)
Call-to-balloon time (min)
 ≤904351 (25.7%)150 (3.4)
 >90–1053061 (18.1%)127 (4.1)
 >105–1202784 (16.5%)120 (4.3)
 >120–1352052 (12.1%)116 (5.7)
 >135–1501423 (8.4%)82 (5.8)
 >150–1801412 (8.4%)101 (7.2)
 >180–2401232 (7.3%)135 (11.0)
 >240–360592 (3.5%)67 (11.3)
  • Diabetes: pre-hospital diagnosis.

  • Hypertension: treated or untreated.

  • Hypercholesterolaemia: total cholesterol >5.2 mmol/L or on lipid-lowering treatment.

  • Renal disease: creatinine >200 µmol/L, functioning transplant or renal failure on dialysis.

  • Out of hours: Monday to Friday 18:00–08:00 hours and weekends.

  • Admission route: Direct: STEMI in the community taken directly to PPCI hospital; Transfer: STEMI in the community taken to or self-presenting to non-PPCI hospital; Non-PPCI IP: STEMI while an inpatient in a non-PPCI hospital; PPCI IP: STEMI while an inpatient in a PPCI hospital; Centre volume: number of PPCI cases by centre. CABG, coronary artery bypass graft surgery; PCI, percutaneous coronary intervention; PPCI, primary PCI; STEMI, ST segment elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction.